HomeInsights52 Week High Stocks

Marksans Pharma Ltd 52 Week High

Marksans Pharma Ltd 52 Week High

stocks purchased

₹ 4.6 Cr

Volume transacted

stocks purchased

163.7 K

stocks traded

Last Updated time: 18 Sep 9.00 AM

Image

Marksans Pharma Ltd

NSE: MARKSANS

YEARHIGH

298.7

Last updated: 18 Sep 24

Key Highlights

  • The 52 Week HIGH of Marksans Pharma Ltd is ₹ 298.7 as of 18 Sep 24.

Company Fundamentals for Marksans Pharma Ltd

No data available

Share price Over Time

1M

1Y

3Y

5Y

Monitoring Marksans Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Share Price

Date
leftPriceleft
18 Sep 2024281.25
17 Sep 2024296.25
16 Sep 2024293.85
13 Sep 2024277.35
12 Sep 2024268.1
11 Sep 2024272.85
10 Sep 2024263.5
09 Sep 2024258.5
06 Sep 2024263
05 Sep 2024259.3

Asset Value vs Market Value of Marksans Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Marksans Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Marksans Pharma Ltd

No data available

* All values are in crore

Marksans Pharma Ltd News Hub

News

Marksans Pharma announces receipt of UKMHRA approval for Fluoxetine capsules

Marksans Pharma'announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

21 Aug 202420:00

News

Marksans Pharma's Verna unit successfully completes USFDA inspection

Marksans Pharma announced that he USFDA has issued an Establishment Inspection Report (EIR...

Read more

20 Aug 202414:37

News

Marksans Pharma to convene AGM

Marksans Pharma announced that the Annual General Meeting (AGM) of the company will be hel...

Read more

20 Aug 202410:46

News

Marksans Pharma gets EIR from USFDA for Goa facility

The inspection has been classified as voluntary action indicated (VAI) and has been closed...

Read more

20 Aug 202414:48

News

Marksans Pharma surges after Q1 PAT rises 29% YoY to Rs 89 cr

Revenue from operations jumped 18.12% YoY to Rs 590.62 crore in first quarter of FY25, dri...

Read more

14 Aug 202412:04

News

Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets

Marksans Pharma announced that its wholly owned subsidiary Relonchem has received Marketin...

Read more

02 Aug 202416:12

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Marksans Pharma Ltd

What is the significance of Marksans Pharma Ltd reaching its 52-week high?

Marksans Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Marksans Pharma Ltd 52-week high?

Investors monitor Marksans Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Marksans Pharma Ltd a good buy when it hits its 52-week high?

Whether Marksans Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Marksans Pharma Ltd fundamentals.

What should I consider before investing in Marksans Pharma Ltd at its 52-week high?

Before investing in Marksans Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Marksans Pharma Ltd stock price continue to rise after reaching its 52-week high?

Marksans Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*